News & Updates
Showing Respirology articles
Showing
Better CV health tied to lower severe COVID-19 risk in adults without CVD
In the C4R* consortium, better cardiovascular health (CVH)—as quantified by the AHA’s** Life’s Essential 8 (LE8)—is associated with a lower risk of severe COVID-19 (ie, hospitalization or death) in individuals without clinical cardiovascular disease (CVD).
Better CV health tied to lower severe COVID-19 risk in adults without CVD
15 hours ago
Nirsevimab prevents RSV-related hospitalizations, severe disease in infants
Treatment with nirsevimab has been shown to bring down the number of hospitalizations due to respiratory syncytial virus (RSV) infections and prevent the development of severe disease in infants, according to a study presented at ESPID 2026.
Nirsevimab prevents RSV-related hospitalizations, severe disease in infants
a day ago
Fluvoxamine wins, metformin disappoints in long COVID fatigue
The antidepressant fluvoxamine reduces long COVID fatigue, whereas the antidiabetic agent metformin fails to outperform placebo in the randomized REVIVE-TOGETHER trial.
Fluvoxamine wins, metformin disappoints in long COVID fatigue
19 Jun 2026
Reduced RT plus chemo-immunotherapy feasible in older/frail NSCLC patients
In older or frail patients with stage III non-small cell lung cancer (NSCLC), undergoing reduced radiotherapy (RT) followed by sequential chemo-immunotherapy results in survival outcomes similar to standard RT, indicating its utility in vulnerable populations, suggests a study.
